Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
See Latest ArticlesBreast-Conserving Surgery in BRCA1/2 Mutation Carriers: Are We Approaching an Answer
Annals of Surgical Oncology, 08/04/09
Garcia–Etienne CA et al. – The data suggest that IBTR risk after BCS in BRCA1/2 mutation carriers is increased compared with patients who have sporadic breast cancer. Likewise, the risk of CBC seems to be increased in this group. These risks and the likelihood of developing new primary tumors should be discussed with carriers interested in breast conservation as well as when choosing risk–reducing strategies.
Related Articles
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09
Relevance Score: 97%
New-Onset Breast Tenderness After Initiation of Estrogen Plus Progestin Therapy and Breast Cancer Risk
Archives of Internal Medicine, 10/13/09
Relevance Score: 97%
Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: The UK MARIBS study
Breast Cancer Research, 11/17/09
Relevance Score: 96%
Breast-feeding the last born child and risk of ovarian cancer
Cancer Causes and Control, 11/16/09
Relevance Score: 96%
Novel breast tissue feature strongly associated with risk of breast cancer
Journal of Clinical Oncology, 10/08/09
Relevance Score: 96%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical Significance of Tumor Necrosis Factor Receptor Superfamily Member 11b Polymorphism in Prostate Cancer
Annals of Surgical Oncology, 03/16/10
Antineoplastic Effects of Decitabine, an Inhibitor of DNA Promoter Methylation, in Adrenocortical Carcinoma Cells
Archives of Surgery, 03/16/10
Effects of peri-operative immunonutrition on cell-mediated immunity, T helper type 1 (Th1)/Th2 differentiation, and Th17 response after pancreaticoduodenectomy
Surgery, 03/15/10
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Analysis of risk factors of surgical site infections in breast cancer
Chinese Medical Journal, 03/16/10
Does Lapatinib Work against HER2-negative Breast Cancers
Clinical Cancer Research, 03/16/10
A Longitudinal Comparison of Arm Morbidity in Stage I–II Breast Cancer Patients Treated with Sentinel Lymph Node Biopsy, Sentinel Lymph Node Biopsy Followed by Completion Lymph Node Dissection, or Axillary Lymph Node Dissection
Annals of Surgical Oncology, 03/15/10
Article Search
Sponsor
Sponsor